Suppr超能文献

2型糖尿病合并非酒精性脂肪性肝病的临床病理特征及相关危险因素

Clinico-pathological features and related risk factors of Type-2 diabetes mellitus complicated with nonalcoholic fatty liver.

作者信息

Chen Lisha, Jiang Li

机构信息

Lisha Chen, Department of Infectious Diseases, Wenling First People's Hospital, Wenling 317500, Zhejiang Province, P.R. China.

Li Jiang, Department of Infectious Diseases, Wenling First People's Hospital, Wenling 317500, Zhejiang Province, P.R. China.

出版信息

Pak J Med Sci. 2022 Sep-Oct;38(7):1771-1775. doi: 10.12669/pjms.38.7.6289.

Abstract

OBJECTIVES

To analyze the clinicopathological features and risk factors of Type-2 diabetes mellitus (T2DM) patients with non-alcoholic fatty liver disease (NAFLD).

METHODS

The data of 145 patients with T2DM who received treatment in our hospital from May 2020 to May 2021 were collected. The patients were diagnosed with NAFLD by abdominal liver Doppler ultrasound; The general data and laboratory examination indexes of T2DM patients with and without NAFLD were compared; To analyze the risk factors of NAFLD in T2DM patients.

RESULTS

According to the results of the ultrasound examination, 71(48.97%) patients were simple T2DM, and 74(51.03%) patients were T2DM with NAFLD. Compared with simple T2DM, T2DM patients with NAFLD had higher BMI, hypertension, fasting plasma glucose(FPG), insulin resistance, triglycerides (TG), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and uric acid(UA) (<0.05). Further logistic regression analysis showed a higher BMI (=1.841, =0.013), FPG (=1.576, =0.014), insulin resistance (=4.195, <0.001) and elevated TG (=4.676, =0.042) are risk factors for T2DM with NAFLD.

CONCLUSION

High BMI, BPG, insulin resistance index and TG are independent risk factors for nonalcoholic fatty liver in T2DM patients. During intervention, attention should be paid to the monitoring of these indicators to effectively prevent the aggravation of the disease.

摘要

目的

分析2型糖尿病(T2DM)合并非酒精性脂肪性肝病(NAFLD)患者的临床病理特征及危险因素。

方法

收集2020年5月至2021年5月在我院接受治疗的145例T2DM患者的数据。通过腹部肝脏多普勒超声诊断患者是否患有NAFLD;比较合并和未合并NAFLD的T2DM患者的一般资料和实验室检查指标;分析T2DM患者发生NAFLD的危险因素。

结果

根据超声检查结果,71例(48.97%)患者为单纯T2DM,74例(51.03%)患者为T2DM合并NAFLD。与单纯T2DM相比,T2DM合并NAFLD患者的体重指数、高血压、空腹血糖(FPG)、胰岛素抵抗、甘油三酯(TG)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)和尿酸(UA)更高(<0.05)。进一步的逻辑回归分析显示,较高的体重指数(=1.841,=0.013)、FPG(=1.576,=0.014)、胰岛素抵抗(=4.195,<0.001)和升高的TG(=4.676,=0.042)是T2DM合并NAFLD的危险因素。

结论

高体重指数、BPG、胰岛素抵抗指数和TG是T2DM患者非酒精性脂肪肝的独立危险因素。在干预过程中,应注意对这些指标的监测,以有效预防疾病加重。

相似文献

3
Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.
Exp Ther Med. 2018 Mar;15(3):2936-2940. doi: 10.3892/etm.2018.5753. Epub 2018 Jan 16.
4
[Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Zhonghua Gan Zang Bing Za Zhi. 2014 Aug;22(8):631-5. doi: 10.3760/cma.j.issn.1007-3418.2014.08.016.
9
Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
Genet Mol Res. 2015 Apr 10;14(2):2940-6. doi: 10.4238/2015.April.10.1.
10
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.

引用本文的文献

1
The interplay between diabetes and non-alcoholic fatty liver disease: a cross-sectional study from Pakistan.
Ann Med Surg (Lond). 2024 Feb 28;86(4):1929-1932. doi: 10.1097/MS9.0000000000001875. eCollection 2024 Apr.
3
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus-The Chicken or the Egg Dilemma.
Biomedicines. 2023 Apr 4;11(4):1097. doi: 10.3390/biomedicines11041097.

本文引用的文献

2
Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients.
J Pers Med. 2021 Mar 23;11(3):238. doi: 10.3390/jpm11030238.
3
Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population.
J Diabetes Complications. 2021 May;35(5):107874. doi: 10.1016/j.jdiacomp.2021.107874. Epub 2021 Feb 16.
6
Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes.
Clin Geriatr Med. 2020 Aug;36(3):527-547. doi: 10.1016/j.cger.2020.04.010. Epub 2020 Apr 17.
7
Fracture Risk Assessment Tool May Not Indicate Bone Fragility in Women With Type 2 Diabetes.
Am J Med Sci. 2020 Nov;360(5):552-559. doi: 10.1016/j.amjms.2020.04.002. Epub 2020 Apr 11.
8
Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?
Hepatobiliary Surg Nutr. 2020 Apr;9(2):239-241. doi: 10.21037/hbsn.2019.10.21.
10
Association of liver biomarkers and cytokeratin-18 in Nonalcoholic fatty liver disease patients.
Pak J Med Sci. 2020 Mar-Apr;36(3):387-390. doi: 10.12669/pjms.36.3.1674.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验